Table 4.
The effects of a 6-week administration of 13-cis-RA (1 mg/kg/day, i.p.) and a 1-week administration of BLEB (125 nmol/day, intra-arterial) on basal pressure (BP, cm H2O), voided volume (VV, ml), post-void residual (PVR, ml), intercontraction interval (ICI, s), bladder compliance (BC, ml/cm H2O), detrusor overactivity index (DOI, cm H2O/ml), nonvoiding contractions frequency (FNVC, times/filling phase), and volume threshold to elicit NVC (VTNVC, %)
| Treatment | BP, cm H2O | VV, ml | PVR, ml | ICI, s | BC, ml/cm H2O | DOI, cm H2O/ml | FNVC, times/filling phase | VTNVC, % |
|---|---|---|---|---|---|---|---|---|
| Control | 2.37 ± 0.13 | 0.82 ± 0.03 | 0.05 ± 0.004 | 943.8 ± 26.52 | 0.21 ± 0.006 | 66.60 ± 6.75 | 0.41 ± 0.05 | 85.47 ± 4.72 |
| 13-cis-RA | 3.48 ± 0.26** | 0.61 ± 0.04** | 0.06 ± 0.004 | 813.9 ± 28.65* | 0.18 ± 0.006 | 143.0 ± 13.79*** | 2.34 ± 0.28*** | 58.12 ± 5.00*** |
| BLEB | 2.53 ± 0.24 | 0.71 ± 0.06 | 0.06 ± 0.004 | 891.3 ± 43.14 | 0.17 ± 0.008* | 64.07 ± 5.81 | 0.99 ± 0.22 | 63.35 ± 4.32** |
| 13-cis-RA + BLEB | 2.58 ± 0.23# | 0.80 ± 0.05# | 0.07 ± 0.006 | 1022.0 ± 52.33### | 0.22 ± 0.012## | 74.07 ± 5.99### | 1.39 ± 0.20## | 93.26 ± 5.67### |
*p < 0.05, **p < 0.01, ***p < 0.001 vs control, #p < 0.05, ##p < 0.01, ###p < 0.001 vs. 13-cis-RA, by the two-way analysis of variance (two-way ANOVA) followed by a Bonferroni post hoc test, n = 15 in each group. BP: 13-cis-RA effect [F(1,56) = 6.413, p = 0.0142], BLEB effect [F(1,56) = 2.655, p = 0.1088), 13-cis-RA × BLEB interaction [F(1,56) = 5.417, p = 0.0236)]. VV: 13-cis-RA effect [F(1,56) = 1.410, p = 0.2401], BLEB effect [F(1,56) = 2.655, p = 0.3603), 13-cis-RA × BLEB interaction [F(1,56) = 0.8508, p = 0.0042)]. PVR: 13-cis-RA effect [F(1,56) = 1.759, p = 0.1902], BLEB effect [F(1,56) = 5.545, p = 0.0221), 13-cis-RA × BLEB interaction [F(1,56) = 0.5690, p = 0.4538)]. ICI: 13-cis-RA effect [F(1,56) = 1.759, p = 0.1902], BLEB effect [F(1,56) = 5.545, p = 0.0221), 13-cis-RA × BLEB interaction [F(1,56) = 0.5690, p = 0.4538)]. BC: 13-cis-RA effect [F(1,56) = 1.657, p = 0.2033], BLEB effect [F(1,56) = 0.09135, p = 0.7636), 13-cis-RA × BLEB interaction [F(1,56) = 17.62, p < 0.0001)]. DOI: 13-cis-RA effect [F(1,56) = 24.43, p < 0.0001], BLEB effect [F(1,56) = 16.71, p = 0.0001), 13-cis-RA × BLEB interaction [F(1,56) = 0.5690, p = 0.0004)]. FNVC: 13-cis-RA effect [F(1,56) = 30.00, p < 0.0001], BLEB effect [F(1,56) = 0.7746, p = 0.3826), 13-cis-RA × BLEB interaction [F(1,56) = 12.96, p = 0.0007)]. VTNVC: 13-cis-RA effect [F(1,56) = 0.06678, p = 0.7970], BLEB effect [F(1,56) = 1.727, p = 0.1941), 13-cis-RA × BLEB interaction [F(1,56) = 33.41, p < 0.0001)]